Skip to content

Welcome to the new Aloha Fungi shop!

Free delivery in Poland from 299 zł

How does Reishi work? Mechanisms and research

Reishi is studied around the HPA axis, GABA activity and immunomodulation. Three mechanisms, a meta-analysis of n=423 and 2000 years of TCM tradition.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

6 min read

How does Reishi work? Mechanisms and research
Contents

Reishi (Ganoderma lucidum) is one of the best-studied functional mushrooms. Reishi contains over 400 identified bioactive compounds, three groups of which appear most often in the literature: triterpenes, β-glucans and peptidoglycans. This article covers what is actually known about them, not what is promised about them.

What are the three main mechanisms of Reishi?

In scientific literature, Reishi is studied in the context of three mechanisms: regulation of the HPA axis (triterpenes linked to evening cortisol), GABA-ergic activity (modulation of the parasympathetic nervous system) and immunomodulation (β-glucans activating the Dectin-1 receptor). This is a description of molecular mechanisms from research, not a guarantee of an effect for any individual reader.

These three pathways do not act in isolation. Triterpenes (including ganoderic acid A, B, C) modulate glucocorticoid receptors in the hypothalamus, β-1,3/1,6-glucans bind to immune cells, and Ganoderma peptidoglycans round out the profile. In the classical Chinese pharmacopoeia Shen Nong Ben Cao Jing, Reishi is the only mushroom classified in the shang yao class, the highest class of regulatory herbs, alongside ginseng.

What does research show about Reishi and the HPA axis?

The hypothalamic-pituitary-adrenal (HPA) axis regulates the daily cortisol rhythm. In vitro and animal-model studies show Reishi triterpenes affecting glucocorticoid receptors and parasympathetic activity, a topic the literature connects to evening cortisol.

The strongest evidence to date is a 2023 meta-analysis by Chu and colleagues, published in Frontiers in Pharmacology. It pooled results from 5 randomized clinical trials (n=423 total) and found a statistically significant reduction in the Pittsburgh Sleep Quality Index (PSQI) score in the Reishi group versus placebo [Chu et al. 2023, DOI: 10.3389/fphar.2023.1120021]. This is meta-analysis-level evidence, the strongest currently available on Reishi and sleep quality, but it still describes a study group, not a promise to a single reader.

According to Dr. Wang Xiao, author of a literature review on Reishi published in Mycology:

"Ganoderma lucidum is classified as an adaptogen, used in traditional Chinese and Japanese medicine for over two thousand years. Modern research points mainly to potential mechanisms through modulation of the immune system, antioxidant activity and effects on the nervous system."

· Wang X, Lin Z. (2017). Mycology 8(2): 121-131.

Sleep depends on dozens of factors. Supplementation is one element, not a standalone solution.

What is Reishi's GABA-ergic activity?

GABA is the main inhibitory neurotransmitter in the central nervous system. In animal-model studies, Reishi extended total sleep time by 15-23% and shortened sleep latency, though the molecular mechanism is not fully mapped.

Some research points to an effect on parasympathetic dominance, the shift from the sympathetic system (mobilization) to the parasympathetic system (rest), which is key for falling asleep. Reishi also contains adenosine, a nucleoside that naturally accumulates in the brain during the day, building what is known as sleep pressure.

How does immunomodulation through Reishi's β-glucans work?

The third mechanism is immunomodulation through β-glucans, structural polysaccharides that can make up to 40% of dry fruiting-body mass in quality extracts. Reishi β-glucans bind to the Dectin-1 receptor on dendritic cells, macrophages and neutrophils [Brown et al. 2003, DOI: 10.1084/jem.20021890].

Dectin-1 activation triggers the Syk-CARD9-NF-κB pathway, leading to cytokine production and modulation, not just activation, of the immune response. This distinction matters: an immunomodulator does not "boost immunity" in a general sense, it restores regulation, potentially quieting overreactivity or supporting a deficient response.

What does Reishi have to do with TCM tradition?

The classical Chinese pharmacopoeia Shen Nong Ben Cao Jing (2nd century BCE) divided herbs into three classes: shang yao (regulators for long-term use), zhong yao (supporting agents, used temporarily) and xia yao (potent agents for precise use). Reishi is the only mushroom in the shang yao class.

Ethnomycologist Christopher Hobbs, author of Medicinal Mushrooms: An Exploration of Tradition, Healing, and Culture, writes:

"Reishi in the classical Chinese pharmacopoeia is the only mushroom classified in the highest shang yao class, the 'ruler' herbs that regulate rather than treat symptoms. It was used not as a medicine for specific diseases, but as a tonic supporting long-term health and balance."

· Hobbs C. (2003). Botanica Press.

In TCM practice, Reishi is traditionally associated with tonifying Heart Qi and calming Shen (spirit, consciousness). This is a cultural and traditional description, not a medical diagnosis in the Western sense. If you're curious how this tradition translates into everyday habits, read about the evening ritual with Reishi.

What do clinical trials with Reishi actually show?

StudynResult
Chu et al. 2023 (meta-analysis)423 (5 RCTs)Statistically significant PSQI improvement vs placebo
Lu et al. 2019 (pilot)32PSQI improvement in Reishi group
Jiang et al. 2024 (model)modelMicrobiome modulation, reduced behavioral stress markers

Weak points of the literature: no large, multi-center trials (n above 500), heterogeneous preparations (raw fruiting-body powder vs. 10:1 extract vs. ethanol extract), and short observation periods. Reishi has some of the stronger RCT evidence among functional mushrooms in the context of sleep, but it remains a "moderate," not a "conclusive," level of evidence.

When should you consult a doctor about Reishi?

Reishi is a biologically active extract, it requires sensible selection, it is not a neutral relaxing tea. Consult a doctor or pharmacist if you take immunosuppressant medication, anticoagulants or hypoglycemic medication, if you are pregnant or breastfeeding, or if you have surgery planned within the next two weeks. Literature shows weak anticoagulant and hypoglycemic activity for Reishi, so these situations require individual assessment. You will find more on which medications call for caution in our post on Reishi and medication interactions.

What are the properties of reishi?

Reishi (Ganoderma lucidum) is the best-known mushroom of Chinese tradition, called the "mushroom of longevity", a regular fixture of evening rituals. The scientific literature on reishi is extensive but uneven: our Research Atlas gathers 11 pieces of literature, including a Cochrane systematic review, and at every entry we describe the quality of the evidence. A food supplement is not for treating disease; reishi is taken as part of a ritual, not instead of a doctor.


This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Reishi in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

8

human studies

3

placebo-controlled RCTs

2005–2025

years of publication

  • Jin X. et al., 2016

    A

    Cochrane systematic review with meta-analysis

    5 RCTs, total number of people not reported

    The review collected randomised studies on the use of Ganoderma lucidum in the context of oncological treatment. The authors noted unsatisfactory methodological quality of the primary studies, incomplete outcome reporting, no long-term survival data, and adverse events reported in only one study.

    PMID 27045603
  • Klupp N.L. et al., 2015

    A

    Cochrane systematic review with meta-analysis

    5 studies, 398 people

    The review collected randomised studies on the effect of Ganoderma lucidum on cardiovascular risk factors in people with type 2 diabetes. The authors noted that only 3 of 5 studies provided data suitable for statistical analysis.

    PMID 25686270
  • Jafari A. et al., 2025

    B

    systematic review with meta-analysis, GRADE assessment

    17 RCTs, 971 people

    The review collected clinical trials on Ganoderma lucidum supplementation regarding anthropometric, metabolic, inflammatory and liver markers. GRADE-assessed evidence quality was very low for all analysed outcomes.

    PMID 40510787
  • Zhong L. et al., 2019

    B

    systematic review with meta-analysis of RCTs

    23 studies, 4246 people

    The review collected randomised studies on Coriolus versicolor and Ganoderma lucidum preparations used as adjunct therapy in oncology patients. Studies were conducted almost exclusively in Asia, with heterogeneous preparations and doses.

    PMID 31333449
  • Klupp N.L. et al., 2016

    C

    RCT, double-blind, placebo-controlled

    84 people

    The study examined the effect of Ganoderma lucidum, alone and combined with Cordyceps sinensis, on glycaemic parameters and other cardiovascular risk factors in 84 people with type 2 diabetes and metabolic syndrome. Observation period limited to 16 weeks.

    PMID 27511742
  • Noguchi M. et al., 2008

    C

    RCT

    88 men over 49 years old

    The study examined the effect of an ethanol extract of Ganoderma lucidum on lower urinary tract symptoms in 88 men over 49 years old. The authors recommended further evaluation on a larger sample and over a longer period.

    PMID 18097505
  • Aref M. et al., 2023

    E

    meta-analysis of animal studies · preclinical studies (in vitro and rodent)

    not applicable, 49 papers

    The review collected animal studies on the effect of Ganoderma lucidum on serum lipid profile. Dose variation between studies, scope limited to animal models.

    PMID 38116485
  • Tang W. et al., 2005

    C

    RCT, double-blind, placebo-controlled

    132 people (China)

    The study examined the effect of 8 weeks of taking a Ganoderma lucidum polysaccharide extract on a neurasthenia symptom severity scale score in 132 Chinese patients. Limitations were not stated explicitly in the abstract.

    PMID 15857210
  • Cui X.Y. et al., 2012

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of a 3-day Ganoderma lucidum extract administration (80 mg/kg) on total sleep time and NREM sleep, and on TNF-α levels in blood and brain, using TNF-α blocking antibodies to test the mechanism.

    PMID 22207209
  • Chu Q.P. et al., 2007

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of an aqueous extract (80 and 120 mg/kg) on sleep architecture in healthy animals and on pentobarbital-induced sleep, using flumazenil to test the GABAergic mechanism.

    PMID 17383716
  • Wang X. et al., 2025

    C

    RCT, double-blind, placebo-controlled

    110 randomised (55/group in final analysis), 12 weeks

    The study examined the effect of 12 weeks of Ganoderma lucidum spore oil supplementation (3 g daily, approx. 1 g triterpenes) on lipid profile and kidney/liver safety in people with borderline elevated triglycerides. Limited to a population with borderline hypertriglyceridemia and a short 12-week observation period.

    PMID 40077714

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™